Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.
Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.
What is the best treatment of drug-resistant trigeminal neuralgia in patients affected by multiple sclerosis? A literature analysis of surgical procedures.
Modulation of CNS autoimmune responses by CD8(+) T cells coincides with their oligoclonal expansion.
Effects of Imatinib Mesylate in Mouse Models of Multiple Sclerosis and In vitro Determinants.
The role of diet in multiple sclerosis.
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes.
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trial.
Using the Multiple Sclerosis Impact Scale to Estimate Health State Utility Values: Mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6D.
[Magnetic reasonance spectroscopy-guided stereotactic biopsy for brain lesion].
Combined sequence-based and genetic mapping analysis of complex traits in outbred rats.
Sulfatides in extracellular vesicles isolated from plasma of multiple sclerosis patients.
The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.
Functional assessment of the visual pathway with multifocal visual evoked potentials, and their relationship with disability in patients with multiple sclerosis.
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.
Effectiveness of Energy-Conservation treatment in reducing fatigue in Multiple Sclerosis: a systematic review and meta-analysis.
Magnetic resonance imaging induced acute midfacial pain - incidental finding of a dislocated dental bur.
MRI characteristics of neuromyelitis optica spectrum disorder: An international update.
Neurotrophic factors and their effects in the treatment of multiple sclerosis.
Multiple sclerosis and oral health--an update.
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Aggressive multiple sclerosis: proposed definition and treatment algorithm.
Self-tolerance in multiple sclerosis.
Anti-aquaporin-4 antibody in Chinese patients with central nervous system inflammatory demyelinating disorders.
Pages
« first
‹ previous
…
236
237
238
239
240
241
242
243
244
…
next ›
last »